Study of Ruxolitinib in Colorectal Cancer Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
The purpose of this study was to determine if ruxolitinib, in combination with regorafenib, is safe and effective in the treatment of metastatic colorectal cancer.
Epistemonikos ID: 61772dfc2e65ddc86ae01754150c4229cec46d28
First added on: May 11, 2024